MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated ...

1 Day PROC -17.12% DJIA 0.97% Russell 2K 1.80% Health Care/Life Sciences 0.14% ...

Pharma Company Procaps Beats On Q3 But Lowers FY23 Guidance: Here's Why Procaps Group SA (NASDAQ: PROC) reported Q3 FY23 revenue of $118.41 million, beating the consensus of $110.4 million and ...

Neutral Dr Reddys Laboratories; target of Rs 1390: Motilal Oswal Nov 06 2024 08:21 PM Hold Dr Reddyu2019s Laboratories; target of Rs 1270: ICICI Securities Nov 06 2024 01:35 PM Sell Dr Reddy's ...

Procaps Group, S.A., a pharmaceutical company, is facing the potential delisting of its ordinary shares from The Nasdaq Capital Market after failing to file its annual report on time. The ...

MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, ...

After hours: November 29 at 4:53 PM EST Loading Chart for ABT ...

Procaps Group (PROC) has released an update. Procaps Group is taking strategic steps to navigate financial challenges, including appointing a new board director and extending forbearance ...